Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-66.76	36.95	111.17
Graham Fair Price	151.99	3.79	1.50
PEG	-96.34	0.02	-0.46
Price/Book	-2.39	1.20	1.23
Price/Cash Flow	-16.45	28.47	-34.08
Prices/Earnings	-83.61	8.75	53.43
Price/Sales	-3.04	2.06	2.12
Price/FCF	-16.45	28.47	-34.08
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	36.22	0.15	0.11
Operating Margin	212.37	0.11	0.04
ROA	504.78	< 0.005	< 0.005
ROE	< 0.005	0.03	495.67
ROIC	< 0.005	< 0.005	340.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.02	-75.08
Dividends QOQ	-0.41	0.95	132.13
EBIT QOQ	4.67	2.25	-51.91
EPS QOQ	1.17	5.25	348.17
FCF QOQ	0.85	2.21	159.03
Revenue QOQ	-0.12	0.04	-66.42
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	26.12	45.07	72.51
Days Sales Outstanding (DSO)	64.30	71.12	10.61
Inventory Turnover	3.45	2.00	-42.03
Debt/Capitalization	0.81	0.81	-0.34
Quick Ratio	0.57	0.58	2.53
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	4.18	6.60	57.66
Cash	3.18	3.07	-3.55
Capex	-0.69	0.48	-31.48
Free Cash Flow	-0.15	0.18	20.62
Revenue	2.42	2.52	3.94
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.75	0.71	-5.95
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	85.78	28.54	-66.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating